Samantha joined Drug Discovery News as an intern in 2023. She is currently pursuing her PhD at the University of Washington, where she studies scaling up DNA nanotechnology for new applications and develops science education and outreach materials for various audiences. She enjoys stand-up comedy, science fiction movies, and picturing her life as a sci-fi mockumentary sitcom.
Researchers identified a peptide that selectively blocks pain signaling in sensory neurons and packaged it into a viral-based gene therapy in a step towards treating chronic pain without the risk for addiction.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.